Alectinib Side Effects
Applies to alectinib: oral capsule.
Serious side effects of Alectinib
Along with its needed effects, alectinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking alectinib:
More common
- Bloody urine
- chest pain or discomfort
- cough
- decreased frequency or amount of urine
- difficulty with moving
- increased blood pressure
- increased thirst
- joint pain or swelling
- loss of appetite
- lower back or side pain
- lightheadedness, dizziness, or fainting
- muscle aching or cramping
- muscle pains or stiffness
- nausea
- slow or irregular heartbeat
- swelling of the face, fingers, or lower legs
- trouble breathing
- unusual tiredness or weakness
- vomiting
- weight gain
Less common
- Clay-colored stools
- dark urine
- decreased appetite
- fever
- headache
- itching or skin rash
- stomach pain or tenderness
- yellow eyes or skin
Rare
- Difficulty breathing
Incidence not known
- Back, leg, or stomach pains
- bleeding gums
- chills
- general body swelling
- nosebleeds
- pale skin
- sore throat
Other side effects of Alectinib
Some side effects of alectinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Back pain
- bloating or swelling of the face, arms, hands, lower legs, or feet
- blurred vision
- difficulty having a bowel movement
- double vision
- lack or loss of strength
- rapid weight gain
- rash with flat lesions or small raised lesions on the skin
- seeing double
- seeing floating dark spots or material before the eyes
- swelling around the eyes
- tingling of the hands or feet
- unusual weight gain or loss
- vision changes
Less common
- Change in taste
- loss of taste
For Healthcare Professionals
Applies to alectinib: oral capsule.
Hematologic
Very common (10% or more): Anemia (62%), lymphopenia (14%), neutropenia (14%)
Postmarketing reports: Hemolytic anemia[Ref]
Hepatic
Very common (10% or more): Increased AST (51%), increased alkaline phosphatase (47%), hyperbilirubinemia (39%), increased ALT (34%)[Ref]
Musculoskeletal
Very common (10% or more): Increased CPK (43%), myalgia/musculoskeletal pain (29%), back pain (12%), back pain (12%)[Ref]
Other
Very common (10% or more): Fatigue/asthenia (26%), edema (e.g., peripheral edema, edema, eyelid edema, localized edema, face edema) (22%)[Ref]
Metabolic
Very common (10% or more): Hyperglycemia (36%), hypocalcemia (32%), hypokalemia (29%), hypophosphatemia (21%), hyponatremia (20%), increased weight (11%)[Ref]
Gastrointestinal
Very common (10% or more): Constipation (34%), nausea (18%), diarrhea (16%), vomiting (12%)[Ref]
Renal
Very common (10% or more): Increased creatinine (e.g., increased blood creatinine, creatinine renal clearance decreased, glomerular filtration rate decreased, acute kidney injury) (28%)[Ref]
Dermatologic
Very common (10% or more): Rash (e.g., acneiform dermatitis, erythema, and different types of rash [macular, papular, maculopapular, generalized, and pruritic]) (15%)
Common (1% to 10%): Photosensitivity[Ref]
Nervous system
Very common (10% or more): Headache (17%)
Common (1% to 10%): Dysgeusia/hypogeusia[Ref]
Respiratory
Very common (10% or more): Cough (19%), dyspnea (16%)
Uncommon (0.1% to 1%): Interstitial lung disease[Ref]
Ocular
Very common (10% or more): Vision disorder (e.g., blurred vision, vitreous floaters, visual impairment, reduced visual acuity, asthenopia, diplopia) (10%)[Ref]
Cardiovascular
Very common (10% or more): Bradycardia (11%)[Ref]
Frequently asked questions
More about alectinib
- Check interactions
- Compare alternatives
- Reviews (2)
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
References
1. (2015) "Product Information. Alecensa (alectinib)." Genentech
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.